ARTIVION, INC. (AORT) Operating Margin
- Operating margin · 12 months: Value 4.38%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 4.38% | Operating income / revenue. Period ending 2026-06-30. $20.64M ÷ $471.47M × 100 ≈ 4.38% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 20.64M USD | Operating Income (Loss) |
| Revenue | 471.47M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 167.97M USD | Cost of Goods and Services Sold |
| Research and development | 35.10M USD | Research and Development Expense |
| Selling, general and administration | 254.77M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20.64M | $471.47M | $167.97M | $35.10M | $254.77M | 4.38% |
| 2026-03-31 | $37.39M | $458.69M | $162.59M | $33.10M | $232.61M | 8.15% |
| 2025-12-31 | $33.74M | $441.33M | $157.10M | $30.99M | $226.49M | 7.65% |
| 2025-09-30 | $25.73M | $422.65M | $150.06M | $29.27M | $221.08M | 6.09% |
| 2025-06-30 | $17.59M | $405.04M | $145.84M | $27.80M | $213.81M | 4.34% |
| 2025-03-31 | $15.71M | $390.08M | $140.67M | $28.23M | $205.47M | 4.03% |
| 2024-12-31 | $38.87M | $388.54M | $139.76M | $28.45M | $181.46M | 10.01% |
| 2024-09-30 | $39.38M | $384.90M | $136.53M | $28.69M | $180.30M | 10.23% |
| 2024-06-30 | $33.75M | $376.97M | $133.34M | $28.51M | $181.38M | 8.95% |
| 2024-03-31 | $34.91M | $368.21M | $129.81M | $28.43M | $189.30M | 9.48% |
| 2023-12-31 | $5.74M | $354.00M | $124.83M | $28.71M | $208.98M | 1.62% |
| 2023-09-30 | $6.70M | $339.73M | $120.76M | $29.37M | $197.15M | 1.97% |
| 2023-06-30 | $3.84M | $328.72M | $117.27M | $34.74M | $187.11M | 1.17% |
| 2023-03-31 | $704.00K | $319.81M | $114.27M | $35.97M | $168.85M | 0.22% |
| 2022-12-31 | $6.20M | $313.79M | $111.27M | $38.88M | $157.44M | 1.98% |
| 2022-09-30 | $-7.27M | $313.79M | $110.78M | $40.03M | $170.24M | -2.32% |
| 2022-06-30 | $11.53M | $309.15M | $107.10M | $38.21M | $168.24M | 3.73% |
| 2022-03-31 | $8.31M | $304.96M | $104.57M | $37.92M | $170.09M | 2.72% |
| 2021-12-31 | $8.12M | $298.84M | $101.32M | $35.55M | $169.77M | 2.72% |
| 2021-09-30 | $19.37M | $287.34M | $96.61M | $32.66M | $154.62M | 6.74% |
| 2021-06-30 | $8.32M | $275.60M | $94.19M | $28.44M | $149.31M | 3.02% |
| 2021-03-31 | $5.07M | $257.88M | $86.43M | $25.61M | $140.77M | 1.97% |
| 2020-12-31 | $2.44M | $253.23M | $85.44M | $24.21M | $141.14M | 0.96% |
| 2020-09-30 | $4.16M | $255.03M | $85.28M | $22.95M | $142.64M | 1.63% |
| 2020-06-30 | $5.23M | $257.78M | $85.94M | $23.45M | $143.16M | 2.03% |
| 2020-03-31 | $13.65M | $275.15M | $92.23M | $23.77M | $145.49M | 4.96% |
| 2019-12-31 | $17.04M | $276.22M | $93.21M | $22.96M | $143.01M | 6.17% |
| 2019-09-30 | $16.19M | $274.32M | $92.67M | $24.43M | $141.03M | 5.90% |
| 2019-06-30 | $16.10M | $271.04M | $91.90M | $23.40M | $139.64M | 5.94% |
| 2019-03-31 | $15.01M | $268.40M | $90.37M | $23.28M | $139.75M | 5.59% |
| 2018-12-31 | $9.31M | $262.84M | $89.86M | $23.10M | $140.57M | 3.54% |
| 2018-09-30 | $6.34M | $247.87M | $83.71M | $22.68M | $135.14M | 2.56% |
| 2018-06-30 | $2.55M | $227.27M | $75.97M | $21.73M | $127.03M | 1.12% |
| 2018-03-31 | $1.93M | $206.59M | $68.23M | $20.74M | $115.69M | 0.94% |
| 2017-12-31 | $7.97M | $189.70M | $61.06M | $19.46M | $101.21M | 4.20% |
| 2017-09-30 | $13.27M | $181.91M | $58.43M | $16.94M | $93.26M | 7.30% |
| 2017-06-30 | $17.92M | $183.16M | $59.76M | $16.38M | $89.10M | 9.78% |
| 2017-03-31 | $17.71M | $182.42M | $61.63M | $14.93M | $88.14M | 9.71% |
| 2016-12-31 | $21.82M | $180.38M | $61.48M | $13.45M | $91.55M | 12.10% |
| 2016-09-30 | $21.55M | $175.19M | (m) | $12.14M | $88.44M | 12.30% |
| 2016-06-30 | $18.60M | $166.64M | $59.22M | $11.39M | $85.34M | 11.16% |
| 2016-03-31 | $13.56M | $155.08M | $56.41M | $10.79M | $82.23M | 8.74% |
| 2015-12-31 | $5.35M | $145.90M | $55.18M | $10.44M | $74.93M | 3.67% |
| 2015-09-30 | $2.42M | $143.21M | $56.37M | $9.99M | $74.43M | 1.69% |
| 2015-06-30 | $2.91M | $143.58M | $55.92M | $8.93M | $75.82M | 2.03% |
| 2015-03-31 | $5.59M | $142.74M | $54.26M | $8.45M | $74.45M | 3.91% |
| 2014-12-31 | $8.84M | $144.64M | $53.35M | $8.70M | $73.75M | 6.11% |
| 2014-09-30 | $10.07M | $142.95M | $52.01M | $9.09M | $71.79M | 7.04% |
| 2014-06-30 | $11.62M | $142.13M | $51.64M | $9.44M | $69.44M | 8.17% |
| 2014-03-31 | $12.21M | $140.96M | $51.38M | $8.97M | $68.41M | 8.66% |
| 2013-12-31 | $13.82M | $140.76M | $50.38M | $8.45M | $68.11M | 9.82% |
| 2013-09-30 | $12.89M | $138.11M | $48.96M | $8.04M | $68.22M | 9.33% |
| 2013-06-30 | $11.28M | $135.28M | $48.17M | $7.62M | $68.22M | 8.33% |
| 2013-03-31 | $14.29M | $134.95M | $47.95M | $7.55M | $65.16M | 10.59% |
| 2012-12-31 | $12.61M | $131.72M | $46.70M | $7.26M | $65.15M | 9.58% |
| 2012-09-30 | $13.36M | $129.31M | $45.97M | $6.99M | $63.00M | 10.33% |
| 2012-06-30 | $12.90M | $125.54M | $44.59M | $6.85M | $61.19M | 10.28% |
| 2012-03-31 | $10.82M | $121.73M | $43.10M | $6.83M | $60.98M | 8.89% |
| 2011-12-31 | $11.64M | $119.63M | $43.78M | $6.90M | $57.30M | 9.73% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $9.87M | $116.64M | $48.28M | $5.92M | $49.06M | 8.46% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $14.50M | $111.69M | $41.92M | $5.25M | $50.02M | 12.98% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |